Sulfonium Salt Reagents for the Introduction of Deuterated Alkyl Groups in Drug Discovery

Angew Chem Int Ed Engl. 2023 Nov 27;62(48):e202311058. doi: 10.1002/anie.202311058. Epub 2023 Sep 27.

Abstract

The pharmacokinetics of pharmaceutical drugs can be improved by replacing C-H bonds with the more stable C-D bonds at the α-position to heteroatoms, which is a typical metabolic site for cytochrome P450 enzymes. However, the application of deuterated synthons is limited. Herein, we established a novel concept for preparing deuterated reagents for the successful synthesis of complex drug skeletons with deuterium atoms at the α-position to heteroatoms. (dn -Alkyl)diphenylsulfonium salts prepared from the corresponding nondeuterated forms using inexpensive and abundant D2 O as the deuterium source with a base, were used as electrophilic alkylating reagents. Additionally, these deuterated sulfonium salts were efficiently transformed into dn -alkyl halides and a dn -alkyl azide as coupling reagents and a dn -alkyl amine as a nucleophile. Furthermore, liver microsomal metabolism studies revealed deuterium kinetic isotope effects (KIE) in 7-(d2 -ethoxy)flavone. The present concept for the synthesis of deuterated reagents and the first demonstration of a KIE in a d2 -ethoxy group will contribute to drug discovery research based on deuterium chemistry.

Keywords: Alkylation; Deuteration; Heavy Drugs; Kinetic Isotope Effect; Sulfonium Salts.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytochrome P-450 Enzyme System*
  • Deuterium / chemistry
  • Drug Discovery
  • Salts*
  • Sodium Chloride

Substances

  • Deuterium
  • Salts
  • Cytochrome P-450 Enzyme System
  • Sodium Chloride